We are live on ! Find out more
TNDM icon

Tandem Diabetes Care

331 hedge funds and large institutions have $3.1B invested in Tandem Diabetes Care in 2024 Q3 according to their latest regulatory filings, with 54 funds opening new positions, 107 increasing their positions, 118 reducing their positions, and 41 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,272% more call options, than puts

Call options by funds: $145M | Put options by funds: $10.5M

150% more funds holding in top 10

Funds holding in top 10: 2 → 5 (+3)

32% more first-time investments, than exits

New positions opened: 54 | Existing positions closed: 41

5% more funds holding

Funds holding: 316 → 331 (+15)

5% less capital inflows, than outflows

Capital inflows: $354M | Capital outflows: $371M

9% less repeat investments, than reductions

Existing positions increased: 107 | Existing positions reduced: 118

1.55% less ownership

Funds ownership: 112.77% → 111.23% (-1.5%)

Holders
331
Holders Change
+15
Holders Change %
+4.75%
% of All Funds
4.74%
Holding in Top 10
5
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+150%
% of All Funds
0.07%
New
54
Increased
107
Reduced
118
Closed
41
Calls
$145​M
Puts
$10.5​M
Net Calls
+$134​M
Net Calls Change
+$14.3​M

TNDM Hedge Fund Activity: Q3 2024 in Review

331 of the 6,990 institutional investors tracked by Wall St. Rank reported a position in Tandem Diabetes Care (TNDM) for Q3 2024, worth a combined $3.1B — up 4.6% from $2.96B a quarter earlier.

Buyers outnumbered sellers: 54 funds opened new TNDM positions and 41 closed out — a net gain of 13 holders — while 107 added to existing stakes and 118 trimmed.

The largest buyer was Divisadero Street Capital Management, opening a new position worth an estimated $44.6M. The largest seller was Citadel Advisors, cutting an estimated $61.9M.

  • 331 institutional investors held Tandem Diabetes Care (TNDM) as of Q3 2024, up from 316 in Q2 2024.
  • Funds reported $3.1B of Tandem Diabetes Care stock for Q3 2024, up 4.6% quarter-over-quarter.
  • 54 funds opened new Tandem Diabetes Care positions in Q3 2024 and 41 closed out, a net change of +13 holders.
  • The largest Tandem Diabetes Care buyer in Q3 2024 was Divisadero Street Capital Management, an estimated $44.6M added.
  • The largest Tandem Diabetes Care seller in Q3 2024 was Citadel Advisors, an estimated $61.9M sold.

Based on aggregated 13F filings for Q3 2024.